Digital Science

Liquidia Technologies has filed for a $57.5 million IPO to take its twist on United Therapeutics’ Tyvaso through phase 3. The experimental pulmonary arterial…

A University of Oklahoma researcher, Andrea Contina, and his team have identified the genetic structure of the Painted Bunting, a neotropical migratory…

Akebia Therapeutics is set to merge with Keryx Biopharmaceuticals. The combined company will own potentially complementary kidney disease drugs and a sales…

It turns out that to tell the sex of a Galápagos penguin, all you need is a ruler. In a paper published April 5 in the journal Endangered Species Research,…

Welcome to the latest edition of our weekly EuroBiotech Report. We start this week with Nanobiotix, which saw its stock soar after reporting phase 2/3 soft…

A decade ago, NIH researchers studying an inherited type of deafness in a single extended family managed to identify the mutation responsible. They named the…

Acceleron Pharma and partner Celgene unveiled 24-week data Thursday showing that luspatercept hit its primary and secondary endpoints in a phase 3 trial of…

Opioid abuse and addiction in America has reached epidemic heights. As a nation, we’re spending more than $500 billion annually in health…

The FDA has lifted a clinical hold on Aptose Biosciences’ APTO-253 almost three years after it stopped the blood cancer program. Aptose is now racing to resume…

Shares of Neuronetics have begun trading on the Nasdaq, following a $93.5 million IPO this week, which priced 5.5 million shares of common stock at $17 each,…